Research brief · 2026-09-09
Why Peptide Research Is Mostly Done in Rats
Scroll through the studies on almost any research peptide and a pattern shows up fast: rats, mice, rats. That is not an accident, and not a sign the research is bad. It is how the system is built, and it has a consequence for how much weight those results can carry.
Rodents dominate for practical reasons. A 2013 review in Missouri Medicine by Bryda reports that mice and rats make up about 95 percent of laboratory animals. They are small, inexpensive to house, and breed quickly. A rat lives two to three years, so an entire lifespan of effects fits inside a single study. Their genomes are mapped, inbred strains reduce variation, and diet, injury and environment can be controlled in ways that are impossible with people.
Regulation also puts them first. FDA rules for an investigational new drug application, at 21 CFR 312.23, require pharmacology and toxicology information, historically from animal studies, before a drug can be tested in humans. For peptides in particular, rats are used to answer the first questions: does it survive in the body, where does it go, and does it do anything to tissue.
The problem is translation. A 2006 review in JAMA by Hackam and Redelmeier examined 76 highly cited animal studies and found that only 37 percent were later confirmed in human randomized trials, while 18 percent were contradicted and the rest were never tested. A 2014 analysis in the American Journal of Translational Research reported that fewer than 8 percent of cancer treatments successful in animals succeed in human trials.
The limit is what it means for research peptides. For compounds like BPC-157, nearly the entire evidence base is rodent studies, and they are not approved for human use. A rat result is a reason to run a human trial, not a replacement for one. Anyone weighing a decision about their own health should be talking with a physician about human evidence.
Sources
- Bryda EC, The Mighty Mouse: the impact of rodents on advances in biomedical research
- Missouri Medicine 2013
- Hackam DG, Redelmeier DA, Translation of research evidence from animals to humans
- JAMA 2006
- Mak IW, Evaniew N, Ghert M, Lost in translation: animal models and clinical trials in cancer treatment
- American Journal of Translational Research 2014
- U.S. Food and Drug Administration, 21 CFR 312.23, IND content and format
- Code of Federal Regulations 2024
Peptide Proof reports what studies found. We do not give medical advice, dosing guidance, or treatment recommendations.